
Tesamorelin
Lyophilised powder — vial
Tesamorelin, 99.6% purity, for laboratory research use. A synthetic GHRH-analogue peptide investigated in animal models for growth-hormone-axis signalling.
- Synthetic GHRH-analogue peptide
- ≥ 99.6% purity (HPLC)
- Store lyophilised at −20 °C, protect from light
- Lyophilised powder, single sealed vial
For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.
Certificate of Analysis (COA)20 mg
99.6%
600 AED
| CAS | 218949-48-5 |
| Molecular mass | 5135.9 g/mol |
| Molecular formula | C221H366N72O67S |
| Sequence | — |
| Form | Lyophilised powder, single sealed vial |
| Purity | ≥ 99.6% |
| Storage | −20 °C, protect from light |
| COA | Available on request |
Independently third-party tested · COA available on request.
Research Use Only
This product is intended for laboratory research use only. It is not a drug, food, or cosmetic, and is not intended for human or animal use, diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher or institution acquiring this material for lawful research purposes.
Related Compounds

Retatrutide
Synthetic triple-agonist peptide (GLP-1 / GIP / glucagon receptors)
650 AED

Retatrutide + Cagrilintide
Triple agonist + amylin analogue blend
Peptide research blend (triple-agonist + amylin analogue)
1,250 AED

CJC-1295 No DAC + Ipamorelin
GHRH analogue + GH secretagogue blend
Peptide research blend (GHRH analogue + ghrelin-receptor agonist)
750 AED

CJC-1295 No DAC
Modified GRF (1-29)
Synthetic GHRH-analogue peptide (Modified GRF 1-29)
650 AED
